NCT03701334, A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2– Early Breast Cancer (NATALEE). NIH U.S. National Library of Medicine, 2018
Accessed November 17, 2018 at: